Pharmacopeia

CWP-0089

EPHEDRINE

Cardiovascular · Level 3

Core pharmacology

Class Group

ADRENERGIC

Introduction

Synthetic direct and indirect sympathomimetic with alpha and beta activity

Indications Uses

1. Hypotension during surgery
2.Nocturnal enureisis
3. Diabetic autonomic neuropathy
4.Hiccups
5. Nasal decongestant

Presentation

- Clear colourless solution for injection (3-9mg slow injection, dose repeated ever 3-4 min)
- Oral tablets
- Nasal spray

Main Action

alpha and beta activity

Mechanism of action

direct and indirect sympathomimetic with alpha and beta activity

Physiological effects

1. CVS
- Effects similar to adrenaline but longer duration as drug is not metabolized by MAO or COMT
- Positive inotrope, chronotrope. Increases CO MVO2
- Increases coronary blood flow
- Increased SVR and PVR

2. Resp
- Respiratory stimulant
- Bronchodilation

3. CNS
- Stimulatory effect similar to amphetamine
- Cerebral blood flow increases
- Mydriasis occurs
- Has local anesthetic effects

4. GIT
- Relaxes GI smooth muscle
- Splanchnic vasoconstriciton

5. GU
- Decreased RBF
- Contracts bladder sphincter and relaxes detrusor muscle- acute urinary retention
- Does not cause uterine constriction

6. Metabolic
- Increased hepatic glycogenolysis
- Increased BMR

Adverse Effects Toxicity

Insomnia, anxiety, tremor, headache, dysrhythmias, nausea and vomiting, and chest pain
irritant to mucous membranes
Acute hypertensive crisis with: MAOIs, doxapram, beta-blockers, oxytocin, and ergot alkaloids

Absorption

- Rapidly absorbed orally

Distribution

- Widely distributed and crosses BBB, placenta and breast milk

Metabolism

- Resistant to MAO and COMT. Hepatic metabolism with a major metabolite being active and may have central effects

Excretion

- 50-90% excreted unchanged in urine. Urinary elimination is pH dependent (enhanced by acidic urine)
- Tachyphylaxis rapidly occurs

Half-life

Elimination T1/2 is 6 hours

Route And Dose

IV 3-6mg bolus